- Bloomberg•last month
Fresenius SE’s negotiations to acquire Pfizer Inc.’s pumps and devices business have stalled on valuation, according to people with knowledge of the matter.
- Bloomberg•2 months ago
Nestle SA rose the most in more than four months as investors welcomed the surprise appointment of Fresenius SE’s Ulf Mark Schneider as successor to Chief Executive Officer Paul Bulcke.
Fresenius SE & Co KGaA (FSNUF)
Other OTC - Other OTC Delayed Price. Currency in USD
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||25.10|
|Avg Vol (3m)||140|
|Dividend & Yield||0.62 (0.83%)|